Norges Bank
OLMA icon

Norges Bank’s Olema Pharmaceuticals OLMA Stock Holding History

Norges Bank’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-402,900
Closed -$1.72M – 2133
2022
Q1 		$1.72M Hold
402,900
– – ﹤0.01% 1996
2021
Q4 		$3.77M Buy
+402,900
New +$8.35M ﹤0.01% 1957

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank's OLMA Position: Q2 2022 in Review

Norges Bank sold out of Olema Pharmaceuticals (OLMA) in Q2 2022, closing a stake of 402,900 shares — an estimated $1.72M sold.

Norges Bank first reported a position in OLMA in Q4 2021 and held it in 2 quarters. The position peaked at $3.77M in Q4 2021. 76 funds tracked by Wall St. Rank hold OLMA as of Q2 2022.

  • Norges Bank reported no remaining Olema Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Norges Bank sold 402,900 Olema Pharmaceuticals shares in Q2 2022, an estimated $1.72M.
  • Norges Bank first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Norges Bank's Olema Pharmaceuticals position peaked at $3.77M in Q4 2021.
  • 76 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2022.

Based on Norges Bank's 13F filing for Q2 2022, filed 11 Aug 2022.